KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Retained Earnings (2018 - 2025)

BioNTech SE's Retained Earnings history spans 8 years, with the latest figure at $20.9 billion for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 2.45% to $20.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $20.9 billion, a 2.45% increase, with the full-year FY2025 number at $20.3 billion, down 0.56% from a year prior.
  • Retained Earnings hit $20.9 billion in Q4 2025 for BioNTech SE, down from $21.4 billion in the prior quarter.
  • Over the last five years, Retained Earnings for BNTX hit a ceiling of $21.4 billion in Q3 2025 and a floor of $54.4 million in Q1 2021.
  • Historically, Retained Earnings has averaged $18.2 billion across 5 years, with a median of $20.5 billion in 2024.
  • Biggest five-year swings in Retained Earnings: surged 27920.04% in 2022 and later fell 6.99% in 2025.
  • Tracing BNTX's Retained Earnings over 5 years: stood at $11.3 billion in 2021, then soared by 69.95% to $19.2 billion in 2022, then increased by 10.67% to $21.3 billion in 2023, then decreased by 4.03% to $20.4 billion in 2024, then increased by 2.45% to $20.9 billion in 2025.
  • Business Quant data shows Retained Earnings for BNTX at $20.9 billion in Q4 2025, $21.4 billion in Q3 2025, and $20.7 billion in Q2 2025.